WRBY vs. STVN, GKOS, NARI, IRTC, TMDX, BLCO, SLNO, INSP, PRCT, and NVST
Should you be buying Warby Parker stock or one of its competitors? The main competitors of Warby Parker include Stevanato Group (STVN), Glaukos (GKOS), Inari Medical (NARI), iRhythm Technologies (IRTC), TransMedics Group (TMDX), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), Inspire Medical Systems (INSP), PROCEPT BioRobotics (PRCT), and Envista (NVST). These companies are all part of the "medical equipment" industry.
Warby Parker vs. Its Competitors
Warby Parker (NYSE:WRBY) and Stevanato Group (NYSE:STVN) are both mid-cap medical equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, earnings, valuation, media sentiment, profitability, analyst recommendations and dividends.
In the previous week, Stevanato Group had 4 more articles in the media than Warby Parker. MarketBeat recorded 8 mentions for Stevanato Group and 4 mentions for Warby Parker. Warby Parker's average media sentiment score of 1.21 beat Stevanato Group's score of 0.87 indicating that Warby Parker is being referred to more favorably in the media.
93.2% of Warby Parker shares are held by institutional investors. 18.2% of Warby Parker shares are held by insiders. Comparatively, 0.7% of Stevanato Group shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Stevanato Group has a net margin of 11.14% compared to Warby Parker's net margin of -1.79%. Stevanato Group's return on equity of 10.00% beat Warby Parker's return on equity.
Warby Parker currently has a consensus price target of $22.88, indicating a potential upside of 2.81%. Given Warby Parker's higher probable upside, analysts plainly believe Warby Parker is more favorable than Stevanato Group.
Warby Parker has a beta of 2.09, meaning that its share price is 109% more volatile than the S&P 500. Comparatively, Stevanato Group has a beta of 0.55, meaning that its share price is 45% less volatile than the S&P 500.
Stevanato Group has higher revenue and earnings than Warby Parker. Warby Parker is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.
Summary
Stevanato Group beats Warby Parker on 11 of the 17 factors compared between the two stocks.
Get Warby Parker News Delivered to You Automatically
Sign up to receive the latest news and ratings for WRBY and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding WRBY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Warby Parker Competitors List
Related Companies and Tools
This page (NYSE:WRBY) was last updated on 7/4/2025 by MarketBeat.com Staff